Quest Diagnostics 2013 Annual Report Download - page 25

Download and view the complete annual report

Please find page 25 of the 2013 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 131

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131

21
The federal or state governments may bring claims based on our current practices, which we believe are lawful. The
federal and state governments have substantial leverage in negotiating settlements since the amount of potential damages far
exceeds the rates at which we are reimbursed, and the government has the remedy of excluding a non-compliant provider from
participation in the Medicare and Medicaid programs. We believe that, based on our experience with settlements and public
announcements by various government officials, federal and state governments continue to strengthen their enforcement efforts
against perceived healthcare fraud. In addition, legislative provisions relating to healthcare fraud and abuse provide government
enforcement personnel substantially increased funding, powers, penalties and remedies to pursue suspected cases of fraud and
abuse.
We have a long-standing and well-established compliance program. The Quality, Safety & Compliance Committee of
our Board of Directors oversees our compliance program and requires periodic management reports regarding our compliance
program. Our program includes detailed policies and procedures and training programs intended to ensure the strict
implementation and observance of all applicable laws, regulations and Company policies. Further, we conduct in-depth reviews
of procedures and facilities to assure regulatory compliance throughout our operations. We conduct annual training of our
employees on these compliance policies and procedures.
AVAILABLE INFORMATION
We file annual, quarterly and current reports, proxy statements and other information with the Securities and Exchange
Commission (the “SEC”). You may read and copy any document that we file with the SEC at the SEC's public reference room
at 100 F Street, NE, Washington, DC 20549 on official business days during the hours of 10:00 am to 3:00 pm. Please call the
SEC at 1-800-SEC-0330 for information regarding the public reference room. The SEC maintains an internet site that contains
annual, quarterly and current reports, proxy and information statements and other information that issuers (including Quest
Diagnostics) file electronically with the SEC. Our electronic SEC filings are available to the public at the SEC's internet site,
www.sec.gov.
Our internet site is www.QuestDiagnostics.com. You can access Quest Diagnostics' Investor Relations webpage at
www.QuestDiagnostics.com/investor. The information on our website is not incorporated by reference into this Report. We
make available free of charge, on or through our Investor Relations webpage, our proxy statements, Annual Report on Form 10-
K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to those reports filed or furnished
pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as soon as reasonably practical after such
material is filed with, or furnished to, the SEC. We also make available, through our Investor Relations webpage, statements of
beneficial ownership of our equity securities filed by our directors, officers and others under Section 16 of the Exchange Act.
We have a corporate governance webpage. You can access information regarding our corporate governance at
www.QuestDiagnostics.com/governance. We post the following on our corporate governance webpage:
• Directors
• Management
• Code of Business Ethics
• Integrity Commitment
• Values
• Corporate Governance Guidelines
• Charters for the following committees of our Board of Directors: Audit and Finance; Compensation; Executive;
Governance; and Quality, Safety and Compliance
• Certificate of Incorporation
• Bylaws
• Corporate Political Contributions Policy
EXECUTIVE OFFICERS OF THE COMPANY
The following persons serve as executive officers of the Company.
Stephen H. Rusckowski (56) is President and Chief Executive Officer. Prior to joining the Company in May 2012,
since October 2006, he was Chief Executive Officer of Philips Healthcare, the largest unit of Royal Philips Electronics, and a
member of the Board of Management of Royal Philips Electronics and its Executive Committee. Previously, he was CEO of
the Imaging Systems business within Royal Phillips Electronics. Before joining Philips in 2001, Mr. Rusckowski held
numerous management positions with the healthcare division of Hewlett-Packard/Agilent Technologies. Mr. Rusckowski has
been a director of the Company since May 2012.